LOCAMETZ 25 ug/1
kit for the preparation of gallium Ga 68 gozetotide · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Novartis Pharmaceuticals Corporation
Locametz is a radioactive imaging agent administered by injection that helps doctors identify somatostatin receptor-positive tumors during positron emission tomography (PET) scans. It is used to locate certain neuroendocrine and other cancers in patients.
Key Facts
- Brand Name
- LOCAMETZ
- Generic Name
- kit for the preparation of gallium Ga 68 gozetotide
- NDC Code (Product)
0078-1224- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 25 ug/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA215841
- Marketing Start
- 03/23/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is LOCAMETZ used for?
Locametz is a radioactive imaging agent administered by injection that helps doctors identify somatostatin receptor-positive tumors during positron emission tomography (PET) scans. It is used to locate certain neuroendocrine and other cancers in patients.
Is LOCAMETZ a controlled substance?
LOCAMETZ is not classified as a controlled substance by the DEA.
What is the generic name for LOCAMETZ?
The generic name for LOCAMETZ is kit for the preparation of gallium Ga 68 gozetotide. There are 1 other brand versions of kit for the preparation of gallium Ga 68 gozetotide.
What is the NDC code for LOCAMETZ 25 ug/1?
The NDC (National Drug Code) for LOCAMETZ 25 ug/1 is 0078-1224, listed by Novartis Pharmaceuticals Corporation.